Multivariate logistic regression analyses: risk factors associated with MS
| . | Subjects with MS, n (%) n = 184 . | Adjusted OR (95% CI) . | P . |
|---|---|---|---|
| Treatment modality | |||
| No transplantation, no CNS irradiation (referent) | 5 (5.2) | ||
| No transplantation, with CNS irradiation | 3 (11.1) | 1.7 (0.3-9.0) | .51 |
| Transplantation without TBI | 1 (5.9) | 1.1 (0.1-14.1) | .96 |
| Transplantation with TBI | 8 (18.6) | 3.9 (1.1-13.3) | .03 |
| Type of leukemia | |||
| AML | 3 (8.8) | ||
| ALL | 14 (9.3) | 0.97 (0.2-4.8) | .97 |
| Sex | |||
| Female (referent) | 9 (10.1) | ||
| Male | 8 (8.4) | 0.7 (0.2-2.0) | .48 |
| Age at evaluation (y) | NA | 1.1 (1.0-1.2) | .13 |
| . | Subjects with MS, n (%) n = 184 . | Adjusted OR (95% CI) . | P . |
|---|---|---|---|
| Treatment modality | |||
| No transplantation, no CNS irradiation (referent) | 5 (5.2) | ||
| No transplantation, with CNS irradiation | 3 (11.1) | 1.7 (0.3-9.0) | .51 |
| Transplantation without TBI | 1 (5.9) | 1.1 (0.1-14.1) | .96 |
| Transplantation with TBI | 8 (18.6) | 3.9 (1.1-13.3) | .03 |
| Type of leukemia | |||
| AML | 3 (8.8) | ||
| ALL | 14 (9.3) | 0.97 (0.2-4.8) | .97 |
| Sex | |||
| Female (referent) | 9 (10.1) | ||
| Male | 8 (8.4) | 0.7 (0.2-2.0) | .48 |
| Age at evaluation (y) | NA | 1.1 (1.0-1.2) | .13 |
NA indicates not applicable.